Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brenton

Showing results (61-70 of 229) with videos related to

Pageof 23
Sort By:
BMC Cancer|September 22, 2017
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancerFiona R James, Mercedes Jiminez-Linan, Jennifer Alsop, et al.
Genome Biology|November 2, 2006
A consensus prognostic gene expression classifier for ER positive breast cancerAndrew E Teschendorff, Ali Naderi, Nuno L Barbosa-Morais, et al.
Gynecologic Oncology Case Reports|December 28, 2013
Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutationHan Hsi Wong, Christine Parkinson, Jonathan A Ledermann, et al.
BMC Cancer|September 4, 2007
High resolution melting for mutation scanning of TP53 exons 5-8Michael Krypuy, Ahmed Ashour Ahmed, Dariush Etemadmoghadam, et al.
Development (Cambridge, England)|July 21, 2000
Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switchR A Drewell, J D Brenton, J F Ainscough, et al.
Oncogene|June 29, 2010
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinomaS L Cooke, C K Y Ng, N Melnyk, et al.
Cytotherapy|October 17, 2022
Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell productsLindsey A Murphy, Russell C Marians, Kristen Miller, et al.
International Journal of Cancer|November 11, 2006
Genomic analysis of the 8p11-12 amplicon in familial breast cancerLorenzo Melchor, Maria J Garcia, Emiliano Honrado, et al.
British Journal of Cancer|August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatmentsJames M S Wason, Jean E Abraham, Richard D Baird, et al.
Oncogene|December 5, 2024
Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatmentMing Li Chia, Flaviu Bulat, Adam Gaunt, et al.
Pageof 23

Showing results (61-70 of 229) with videos related to

Sort By:
Pageof 23
BMC Cancer|September 22, 2017
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancerFiona R James, Mercedes Jiminez-Linan, Jennifer Alsop, et al.
Genome Biology|November 2, 2006
A consensus prognostic gene expression classifier for ER positive breast cancerAndrew E Teschendorff, Ali Naderi, Nuno L Barbosa-Morais, et al.
Gynecologic Oncology Case Reports|December 28, 2013
Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutationHan Hsi Wong, Christine Parkinson, Jonathan A Ledermann, et al.
BMC Cancer|September 4, 2007
High resolution melting for mutation scanning of TP53 exons 5-8Michael Krypuy, Ahmed Ashour Ahmed, Dariush Etemadmoghadam, et al.
Development (Cambridge, England)|July 21, 2000
Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switchR A Drewell, J D Brenton, J F Ainscough, et al.
Oncogene|June 29, 2010
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinomaS L Cooke, C K Y Ng, N Melnyk, et al.
Cytotherapy|October 17, 2022
Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell productsLindsey A Murphy, Russell C Marians, Kristen Miller, et al.
International Journal of Cancer|November 11, 2006
Genomic analysis of the 8p11-12 amplicon in familial breast cancerLorenzo Melchor, Maria J Garcia, Emiliano Honrado, et al.
British Journal of Cancer|August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatmentsJames M S Wason, Jean E Abraham, Richard D Baird, et al.
Oncogene|December 5, 2024
Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatmentMing Li Chia, Flaviu Bulat, Adam Gaunt, et al.
Pageof 23